Last reviewed · How we verify
NCT03350464
Repetitive Transcranial Magnetic Stimulation as a Treatment for Pain in Parkinson's Disease
NA trial testing Repetitive Transcranial Magnetic Stimulation in Parkinson Disease in 11 participants. Completed in 11 December 2018.
11 December 2018
Quick facts
| Lead sponsor | Walton Centre NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 5 April 2018 |
| Primary completion | 11 December 2018 |
| Estimated completion | 11 December 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Repetitive Transcranial Magnetic Stimulation
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Neuropathic Pain — all drugs for Neuropathic Pain →
- Pain — all drugs for Pain →
Sponsor
Walton Centre NHS Foundation Trust
Who can join
Adults 18 to 80, any sex, with Parkinson Disease or Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Transcranial magnetic stimulation (TMS) is a procedure that has been shown to improve pain in chronic sufferers. It is a well-tolerated procedure that can be performed on an outpatient basis. It uses a plastic covered coil that sends a magnetic pulse through the skull into the brain and by targeting particular areas in the brain it can be used to help modulate the perception of pain. The study intends to use this technique to treat such a disabling symptom in patients who suffer from Parkinson's Disease (PD). Initially the aim is to study this technique in ten patients who are suffering from pain and have PD. These patients would initially require an MRI scan which allows us to map the brain and target the correct brain areas for the delivery of the stimulation. The stimulation would be performed over ten sessions and the patients would be assessed by a clinician using well recognized clinical tools. It is anticipated that there will be a meaningful improvement in pain. It is also anticipated that TMS is a safe technique to use in patients with PD. The study will be used to help plan a future study that compares TMS with sham technique to prove whether TMS could be an option in the treatment of such a disabling condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03350464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Repetitive Transcranial Magnetic Stimulation
Trials testing the same drug.
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
- NCT07211490 — rTMS for Cerebellar Ataxia in Children · NA · not yet recruiting
- NCT05139862 — Neurocardiac Predictors of Treatment Response to RTMS in Depression · NA · not yet recruiting
- NCT05883774 — Effects of rTMS on the Anxiety State of Older Patients With GAD · NA · not yet recruiting
- NCT06490965 — Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets · NA · recruiting
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Walton Centre NHS Foundation Trust trials
Trials by the same sponsor.
- NCT06322953 — Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage · Phase 3 · recruiting
- NCT06868342 — Nerve Root Block in Spasticity · NA · completed
- NCT05925088 — Exercise Videos - Perspectives of People Living With Chronic Pain · completed
- NCT05147454 — MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain · active not recruiting
- NCT04356781 — Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Do · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03350464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Walton Centre NHS Foundation Trust
- Last refreshed: 24 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03350464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing